pantoprazole has been researched along with Laryngitis in 5 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Laryngitis: Inflammation of the LARYNGEAL MUCOSA, including the VOCAL CORDS. Laryngitis is characterized by irritation, edema, and reduced pliability of the mucosa leading to VOICE DISORDERS such as APHONIA and HOARSENESS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to determine the clinical and pH-metric effect of treatment with pantoprazole 80 mg for 8 weeks in patients with ear, nose, and throat (ENT) manifestations of gastroesophageal reflux disease associated with pathological proximal acid exposure." | 9.14 | Effect of pantoprazole in patients with chronic laryngitis and pharyngitis related to gastroesophageal reflux disease: clinical, proximal, and distal pH monitoring results. ( Ben Mustapha, N; Besbes, G; Bibani, N; Boubaker, J; Filali, A; Kallel, L; Karoui, S; Matri, S; Sahtout, S; Serghini, M; Zouiten, L, 2010) |
| " Both pantoprazole and placebo resulted in a marked improvement in laryngitis scores (decrease of 8." | 9.10 | Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. ( Eherer, AJ; Friedrich, G; Habermann, W; Hammer, HF; Kiesler, K; Krejs, GJ, 2003) |
| " The aim of this study was to determine the clinical and pH-metric effect of treatment with pantoprazole 80 mg for 8 weeks in patients with ear, nose, and throat (ENT) manifestations of gastroesophageal reflux disease associated with pathological proximal acid exposure." | 5.14 | Effect of pantoprazole in patients with chronic laryngitis and pharyngitis related to gastroesophageal reflux disease: clinical, proximal, and distal pH monitoring results. ( Ben Mustapha, N; Besbes, G; Bibani, N; Boubaker, J; Filali, A; Kallel, L; Karoui, S; Matri, S; Sahtout, S; Serghini, M; Zouiten, L, 2010) |
| " Both pantoprazole and placebo resulted in a marked improvement in laryngitis scores (decrease of 8." | 5.10 | Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. ( Eherer, AJ; Friedrich, G; Habermann, W; Hammer, HF; Kiesler, K; Krejs, GJ, 2003) |
| "Extraesophageal manifestations of gastroesophageal reflux disease (GERD) can include upper airway disorders, asthma and chronic cough." | 2.43 | Extraesophageal manifestations of GERD: diagnosis and therapy. ( Halstead, LA, 2005) |
| "Gastroesophageal reflux (GER) is associated with a variety of laryngopharyngeal signs and symptoms." | 1.31 | Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux. ( Fuleihan, N; Hamdan, AL; Sharara, AI; Younes, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karoui, S | 1 |
| Bibani, N | 1 |
| Sahtout, S | 1 |
| Zouiten, L | 1 |
| Kallel, L | 1 |
| Matri, S | 1 |
| Serghini, M | 1 |
| Ben Mustapha, N | 1 |
| Boubaker, J | 1 |
| Besbes, G | 1 |
| Filali, A | 1 |
| Eherer, AJ | 1 |
| Habermann, W | 2 |
| Hammer, HF | 1 |
| Kiesler, K | 1 |
| Friedrich, G | 2 |
| Krejs, GJ | 1 |
| Halstead, LA | 1 |
| Eherer, A | 1 |
| Lindbichler, F | 1 |
| Raith, J | 1 |
| Hamdan, AL | 1 |
| Sharara, AI | 1 |
| Younes, A | 1 |
| Fuleihan, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-Controlled Assessment of Lansoprazole 30 mg Bid in the Treatment of Gastroesophageal Reflux Associated With Laryngitis[NCT00369265] | Phase 4 | 18 participants (Actual) | Interventional | 2006-08-31 | Terminated (stopped due to Pharmaceutical company purchased by another company and funding was terminated.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for pantoprazole and Laryngitis
| Article | Year |
|---|---|
Extraesophageal manifestations of GERD: diagnosis and therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; | 2005 |
2 trials available for pantoprazole and Laryngitis
| Article | Year |
|---|---|
Effect of pantoprazole in patients with chronic laryngitis and pharyngitis related to gastroesophageal reflux disease: clinical, proximal, and distal pH monitoring results.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Chronic Disease; Esophageal pH Monitorin | 2010 |
Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cross-Over | 2003 |
2 other studies available for pantoprazole and Laryngitis
| Article | Year |
|---|---|
Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; | 1999 |
Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophag | 2001 |